Back to NORTHERN TRUST CORP NORTHERN TRUST CORP

OCULOCUL
Showing 8 of 30 quarters

Position history for NORTHERN TRUST CORPNORTHERN TRUST CORP's holdings in OCULAR THERAPEUTIX INC

NORTHERN TRUST CORP holds 1.8M shares of OCUL (OCULAR THERAPEUTIX INC), worth $17.7M as of 2026-Q2. The position was increased (+17.9% shares). OCUL represents 0.0% of NORTHERN TRUST CORP's portfolio.

Current Value

$17.7M

Current Shares

1.8M

Total Value Change

+$6.8M

Total Shares Change

+552,729

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.8M
+17.9%
$17.7M0.0%$9.82
33
2026-Q1
Increased
1.5M
+4.3%
$12.9M0.0%$10.76
29
2025-Q4
Increased
1.5M
+24.4%
$17.8M0.0%$12.20
35
2025-Q3
Increased
1.2M
+1.6%
$13.7M0.0%$12.53
28
2025-Q2
Decreased
1.2M
-10.4%
$10.7M0.0%$9.22
0
2025-Q1
Decreased
1.3M
-1.8%
$9.5M0.0%$7.58
0
2024-Q4
Increased
1.3M
+5.5%
$11.2M0.0%$8.35
29
2024-Q3
Increased
1.2M
+15.5%
$10.8M0.0%$8.68
32

Other major holders of OCUL: FMR LLC, BlackRock, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used